Literature DB >> 19561630

Stereotactic radiosurgery alone to treat brain metastases.

Laura A Vallow.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19561630     DOI： 10.1038/nrclinonc.2009.84

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

2.  A randomized trial of surgery in the treatment of single metastases to the brain.

Authors:  R A Patchell; P A Tibbs; J W Walsh; R J Dempsey; Y Maruyama; R J Kryscio; W R Markesbery; J S Macdonald; B Young
Journal:  N Engl J Med       Date:  1990-02-22       Impact factor: 91.245

3.  Long-term survivors after gamma knife radiosurgery for brain metastases.

Authors:  Douglas Kondziolka; Juan J Martin; John C Flickinger; David M Friedland; Adam M Brufsky; Joseph Baar; Sanjiv Agarwala; John M Kirkwood; L Dade Lunsford
Journal:  Cancer       Date:  2005-12-15       Impact factor: 6.860

4.  Five-year survivors of brain metastases: a single-institution report of 32 patients.

Authors:  Samuel T Chao; Gene H Barnett; Stephanie W Liu; Alwyn M Reuther; Steven A Toms; Michael A Vogelbaum; Gregory M M Videtic; John H Suh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-08-14       Impact factor: 7.038

5.  Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications.

Authors:  William F Regine; Jennifer L Huhn; Roy A Patchell; William H St Clair; James Strottmann; Ali Meigooni; Michael Sanders; A Byron Young
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

6.  Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases.

Authors:  L E Gaspar; C Scott; K Murray; W Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-07-01       Impact factor: 7.038

7.  Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone.

Authors:  Stephen M Sawrie; Barton L Guthrie; Sharon A Spencer; Robert A Nordal; Ruby F Meredith; James M Markert; Gretchen A Cloud; John B Fiveash
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-04       Impact factor: 7.038

8.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Authors:  David W Andrews; Charles B Scott; Paul W Sperduto; Adam E Flanders; Laurie E Gaspar; Michael C Schell; Maria Werner-Wasik; William Demas; Janice Ryu; Jean-Paul Bahary; Luis Souhami; Marvin Rotman; Minesh P Mehta; Walter J Curran
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

Review 9.  Whole-brain radiotherapy in the management of brain metastasis.

Authors:  Deepak Khuntia; Paul Brown; Jing Li; Minesh P Mehta
Journal:  J Clin Oncol       Date:  2006-03-10       Impact factor: 44.544

10.  A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases.

Authors:  Penny K Sneed; John H Suh; Steven J Goetsch; Seema N Sanghavi; Richard Chappell; John M Buatti; William F Regine; Eduardo Weltman; Vernon J King; John C Breneman; Paul W Sperduto; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-01       Impact factor: 7.038
  10 in total
  1 in total

1.  Evaluating novel radiation techniques for the treatment of cerebral metastases.

Authors:  A J Chalmers
Journal:  Br J Radiol       Date:  2010-02       Impact factor: 3.039
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.